| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $790.8M | +9.2% |
| Cost of Revenue | $86.8M | +12.4% |
| Gross Profit | $704.0M | +8.9% |
| R&D Expense | $301.5M | -11.7% |
| SG&A Expense | $192.9M | +26.9% |
| Operating Income | -$197.3M | +26.0% |
| Pre-tax Income | -$184.2M | +26.6% |
| Income Tax | $4.9M | +1.9% |
| Net Income | -$189.0M | +26.0% |
| EPS (Basic) | -$0.80 | +27.9% |
| EPS (Diluted) | -$0.80 | +27.9% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $199.8M | +8.2% |
| Accounts Receivable | $110.3M | +26.0% |
| Current Assets | $593.3M | -1.2% |
| Total Assets | $844.1M | -5.3% |
| Current Liabilities | $501.0M | +20.5% |
| Total Liabilities | $690.0M | +3.9% |
| Stockholders' Equity | $154.1M | -32.3% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $90.4M | +505.4% |
| Capital Expenditures | $3.8M | -31.9% |
| Investing Cash Flow | $37.2M | +706.4% |
| Financing Cash Flow | -$117.9M | -103.0% |
| Free Cash Flow | $86.6M | +825.3% |